Try our Advanced Search for more refined results

Expert Analysis

The Challenges Facing Trump's Drug Pricing Order

By Tom Bulleit, Deborah Gardner and Scott Falin ( September 25, 2020, 5:04 PM EDT) -- On Sept. 13, President Donald Trump issued a long-anticipated executive order on international reference drug pricing, signaling that rulemaking on the prices that the Medicare program pays for drugs may be underway again. The executive order introduces some new concepts for international reference drug pricing, including, significantly, application to Medicare Part D as well as Part B, and an even lower international reference price....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!